21.218 articles found

Patient preference of device-based treatment of Parkinson's disease.

Aydemir ST, Kumcu MK, Ulukan Ç, Bakirarar B, Akbostancı MC.

Int J Neurosci · 2021-01-05

DOI: 10.1080/00207454.2020.1853723PMID: 33208012

Identification of Common Molecular Signatures Shared between Alzheimer’s and Parkinson’s Diseases and Therapeutic Agents Exploration: An Integrated Genomics Approach

Faruqui NA, Prium DH, Mowna SA, Rahaman TI, Dutta AR, Akter MF.

· 2021-01-04

DOI: 10.1101/2020.12.31.424962

Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease.

Zecca L, Pifl C, Fahn S, Sulzer D, Fariello RG.

NPJ Parkinsons Dis · 2021-01-04

DOI: 10.1038/s41531-020-00149-4PMID: 33397996

Pimavanserin Treatment for Parkinson's Disease Psychosis in Clinical Practice.

Dashtipour K, Gupta F, Hauser RA, Karunapuzha CA, Morgan JC.

Parkinsons Dis · 2021-01-04

DOI: 10.1155/2021/2603641PMID: 33489083

Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson's disease: A double-blind, randomized placebo-controlled trial (Parkinson's Disease Overactive bladder Mirabegron, PaDoMi Study).

Cho SY, Jeong SJ, Lee S, Kim J, Lee SH, Choo MS, Oh SJ.

Neurourol Urodyn · 2021-01-03

DOI: 10.1002/nau.24552PMID: 33389776

Role of Microgliosis and NLRP3 Inflammasome in Parkinson's Disease Pathogenesis and Therapy.

de Araújo FM, Cuenca-Bermejo L, Fernández-Villalba E, Costa SL, Silva VDA, Herrero MT.

Cell Mol Neurobiol · 2021-01-02

DOI: 10.1007/s10571-020-01027-6PMID: 33387119

PINK1 modulators as novel treatments for Parkinson's Disease

Lambourne O.

· 2021-01-01

An Investigation of the Anti-Parkinsonism Potential of Co-enzyme Q₁₀ and Co-enzyme Q₁₀ /Levodopa-carbidopa Combination in Mice.

Onaolapo OJ, Odeniyi AO, Jonathan SO, Samuel MO, Amadiegwu D, Olawale A, Tiamiyu AO, Ojo FO, Yahaya HA, Ayeni OJ, Onaolapo AY.

Curr Aging Sci · 2021-01-01

DOI: 10.2174/1874609812666191023153724PMID: 31702498

Progress and Promise of Nur77-based Therapeutics for Central Nervous System Disorders.

Liu L, Ma D, Zhuo, Pang X, You J, Feng J.

Curr Neuropharmacol · 2021-01-01

DOI: 10.2174/1570159x18666200606231723PMID: 32504502

Transplantation of Stem Cells as a Potential Therapeutic Strategy in Neurodegenerative Disorders.

Ebrahimi T, Abasi M, Seifar F, Eyvazi S, Hejazi MS, Tarhriz V, Montazersaheb S.

Curr Stem Cell Res Ther · 2021-01-01

DOI: 10.2174/1574888x15666200628141314PMID: 32598273

Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases.

Rahman MH, Akter R, Kamal MA.

CNS Neurol Disord Drug Targets · 2021-01-01

DOI: 10.2174/1871527319666200722153611PMID: 32703143

Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals.

Singh M, Singh SP, Yadav D, Agarwal M, Agarwal S, Agarwal V, Swargiary G, Srivastava S, Tyagi S, Kaur R, Mani S.

Curr Gene Ther · 2021-01-01

DOI: 10.2174/1566523220999200817164907PMID: 32811395